The Working Group Webinars and Community Forums provide a virtual space for the PHUSE Project Leads and Community to highlight and share industry topics of interest relating to their Working Groups. These webinars are free and take place virtually.
Details of upcoming webinars are listed below and will be shared via our social media channels. For any inquiries, please contact workinggroups@phuse.global.
To access past webinars, please visit the PHUSE archive.
Upcoming Webinars
The Working Group Webinars and Community Forums provide a virtual space for the PHUSE Project Leads and Community to highlight and share industry topics of interest relating to their Working Groups. These webinars are free and take place virtually. Details of upcoming webinars are listed below and will be shared via our social media channels. For any inquiries, please contact workinggroups@phuse.global. To access past webinars, please visit the PHUSE archive. |
Upcoming Webinars
Date/Time | Type of Webinar | Working Group/Project | Title | Speakers | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
24 October 14:00-15:00 BST / 9:00-10:00 EDT | Real World Evidence | Matthew Reynolds, Azimuth Research Group andTimothy Wolfe, Verantos | ||||||||||||||
20 November 15:00-16: | 00 30 BST / 10:00-11: | 00 30 EDT | Open Source Technology in Clinical Data Analytics (OSTCDA) |
Status | ||||
---|---|---|---|---|
|
Michael Rimler, PHUSE Open Source Technologies Director
Recommended Definition of Treatment-Emergent Adverse Events in Clinical Trials
Registration will open soon!
21 November
14:00-15:
30 BST / 9:00-10:
30 EDT
Responsive Regulation of AI in Drug Development
Registration will open soon!
Previous Webinars
Date/Time | Working Group/Project | Title | Speakers | Recordings |
---|---|---|---|---|
11 October | Open Source Technology in Clinical Data Analytics (OSTCDA) | Open Forum: Open Source Technologies in Clinical Data Analysis | Michael Rimler, PHUSE Open Source Technologies Director | Meetings are not recorded. |
25 September | Anindita Saha, FDA, MiRa Jacobs, FDA and Kausar Riaz Ahmed, Pfizer | |||
13 September | Meetings are not recorded. | |||
12 July | Katja Glaß, Katja Glass Consulting | Meetings are not recorded. | ||
11 July | Jean-Marc Ferran, Independent Consultant, Berber Snoeijer, Clinline and Ariel Berger, Evidera | |||
14 June | Mike Smith, Pfizer | Meetings are not recorded. | ||
17 May | Mike Smith, Pfizer | Meetings are not recorded. | ||
26 April | Michael Rimler, PHUSE Open Source Technologies Director | Meetings are not recorded. | ||
18 April | Michèle Arnoe, IQVIA, Jeffrey Brown, TriNetX andBenjamin Forred, Sanford Research | Recording | ||
17 April | Dr. Junshui Ma, Merck | Recording | ||
21 February | Vera Pomerantseva, ZS Associates | Recording | ||
1 February | Stuart Malcom, Veramed, Sam Hume, CDISC, Jesse Anderson, FDA, Marguerite Kolb, Johnson & Johnson and Nicole Thorne, BMS | Recording | ||
18 January | Real World Evidence | Dr Cheryl Grandinetti, FDA andKris Wenzel, MMS | Recording |